Skip to content
Creator Hubs›Carevive

Carevive

Carevive logo

Remote oncology monitoring that connects clinicians and cancer patients between visits.

Carevive is an oncology health technology company that gives care teams a remote patient monitoring platform to track symptoms, collect patient-reported outcomes, and manage cancer patients between clinic visits. The system is designed to surface actionable data for clinicians while reducing the burden on patients managing complex treatment regimens. On MarketScale, Carevive publishes content for oncology administrators, clinicians, and health systems evaluating remote care management tools.

79 episodes
Channel Brief·Carevive · 79 episodes
Updated Jan 9, 2023

Patient data transforms oncology payment and care models.

Carevive argues that continuous patient-reported outcomes, integrated into clinical workflow, enable both better payment models and real-time symptom management. The channel grounds this in longitudinal registry data and implementation case studies.

Carevive's core argument is that oncology care improves when clinicians capture real-time patient experience data and use it to trigger interventions, not just observe outcomes after the fact. The channel shows this through a registry of over 1,700 patients across 26 cancer types, yielding more than 19,000 completed surveys and 600,000 unique data points over two years, which feed alerts back to care teams during active treatment phases.

Drawn from Carevive’s Longitudinal Data and 1 more →

“Integrating patient-reported outcomes into the workflow leads to improved patient adherence to therapy and reduced hospitalizations and emergency room visits.”

Carevive, Clip 11

By the numbers

600,000

unique data points from patient surveys over two years

1,700+

patients in Carevive registry across 26 cancer types

19,000+

completed surveys over two years in registry

26

cancer types represented in Carevive longitudinal dataset

What the channel argues

DataEOM replaces OCM on July 1, 2023, expanding focus to seven common cancer types with health equity emphasis.→
DataCarevive's registry contains over 1,700 patients across 26 cancer types with 19,000+ surveys and 600,000 data points.→
InsightPlatform alert triggers for moderate to severe symptoms enable care teams to intervene in real-time, improving adherence and reducing hospitalizations.→
InsightPatient compliance with survey follow-ups is high during critical first three months of active treatment.→
InsightReal-world data platforms capture entire patient populations beyond clinical trial cohorts, offering broader perspective on treatment outcomes.→

What you'll learn

•The Oncology Care Model shifts to Enhanced Oncology Model in July 2023, creating new revenue opportunities and care accountability for oncology centers.
•Continuous patient-reported data integrated into clinical workflows generates actionable alerts that drive timely symptom management and improve treatment adherence.
•Real-world longitudinal data from standard-of-care patients reveals patient priorities (cost, treatment decisions) and symptom patterns that differ from historical trial data.
•Carevive's platform serves clinical trials, quality improvement, and post-marketing surveillance by visualizing patient experience across disease stages and treatment phases.
•Patient engagement in remote monitoring remains high when surveys are embedded seamlessly into routine care processes rather than bolted on separately.

What to do about it

→Evaluate transition readiness to Enhanced Oncology Model by mapping seven covered cancer types, identifying gaps in patient engagement infrastructure, and planning PRO integration.
→Implement alert-triggered workflows for moderate to severe symptoms in your care model to test whether real-time intervention improves adherence and reduces ED/hospitalization.
→Leverage real-world patient-reported outcome data for clinical trial endpoint selection and post-launch evidence generation, rather than relying solely on historical trial cohorts.

Who and what shows up

Dr. Aaron Galaznik

Chief Scientific Officer, Carevive

Led webinars on smart data insights in lung cancer, highlighted alert system for moderate to severe symptoms, and discussed longitudinal analysis in breast cancer population.

John Elliot

Vice President of Sales, Carevive

Interviewed on expectations for EOM implementation and revenue-enhancing opportunities in the model transition from OCM.

Dr. Ethan Basch

Expert in electronic patient-reported outcomes

Led webinar discussion on implementing ePROs and optimizing digital remote monitoring in cancer programs.

Michelle Dawn Mooney

Host, Technology and Oncology Podcast

Interviewed John Elliot on revenue-enhancing opportunities and transition strategy for EOM.

Tyler Kern

Host, Oncology and Technology

Interviewed Carevive team members on expectations and implementation of the Enhanced Oncology Model.

Questions this channel answers

Q

What is the Enhanced Oncology Model and how does it differ from OCM?

EOM replaces OCM starting July 1, 2023, supporting clinicians caring for seven common cancer types with focus on health equity and accountable, affordable care. OCM was launched in 2016 to help centers transition from Medicare Fee-for-Service to high-value care.

Revenue Enhancing Opportunities: The Switch from OCM to … →
Q

How does Carevive's data platform improve patient outcomes?

The platform captures real-time patient-reported outcomes, generates alert triggers for moderate to severe symptoms, and feeds temporal summaries back to care teams. Studies show integrating PROs into workflow leads to improved adherence, reduced hospitalizations, and emergency room visits.

CV/COS Webinar: Clip 11 →
Q

What makes Carevive's data unique compared to traditional clinical trial data?

Carevive's registry covers over 1,700 real-world patients across 26 cancer types with continuous, longitudinal data collection. This broader population captures the entire patient spectrum, not just the healthiest trial-eligible cohort, and remains contemporary rather than becoming outdated.

Carevive’s Longitudinal Data →
Q

How do patients engage with remote outcome surveys in oncology?

Patient compliance and persistence with survey follow-ups is impressive during the critical first three months of active treatment when care teams need close monitoring. Engagement is highest when surveys integrate seamlessly into routine care rather than as separate requirements.

Patient Engagement and Compliance →
Q

What patient concerns emerge in lung cancer care from the data?

Top concerns in non-small cell lung cancer cohorts revolve around cost of care and making the right treatment decisions. Patient symptom experience patterns reveal specific burden over treatment timelines that inform personalized care planning.

Patient Insights – Concerns and Symptom Experience over … →
Topics:Patient-reported outcomes (PRO) in oncologyOncology Care Model (OCM) to Enhanced Oncology Model (EOM) transitionReal-world longitudinal data for cancer careRemote symptom monitoring and alert systemsClinical trial design and real-world evidence
Themes:Patient voice as clinical dataReal-time symptom management through alertsLongitudinal outcomes beyond trial cohorts

Industry context

Digital patient-reported outcome platforms are increasingly integrated into oncology care to enable real-time symptom monitoring and automated data capture, reflecting a broader shift toward elevating patient voice in clinical decision-making across the care continuum.

Want a show like this for your brand?

MarketScale produces and distributes branded shows like Carevive for B2B companies.

Book a Demo →